紫鑫藥業(yè)會計信息披露違規(guī)行為案例研究
本文關鍵詞: 會計信息 公司治理 信息披露 出處:《遼寧大學》2016年碩士論文 論文類型:學位論文
【摘要】:信息使用者是通過企業(yè)所披露的會計信息來了解公司經(jīng)營成果、財務狀況等方面的信息,從而做出正確合理的經(jīng)濟決策。會計信息披露質(zhì)量的好壞,對于企業(yè)的公司治理有著非常大的影響,因為其可以反映企業(yè)中高級管理層的治理情況。同時對企業(yè)的中小股東起到一定的保護作用,還可以更好的促使我國證券市場得到健康有序的發(fā)展。最近的幾年來,在信息披露方面上,我國的大部分上市公司都有了不少的改進,但是還是有很多問題仍然不能忽視。我國上市公司在信息披露方面上的違規(guī)行為被越來越多的報道出來,甚至很多公司被有關監(jiān)管部門公開性的責令處罰。目前,我國上市公司在信息披露上仍然存在很多的問題,比如企業(yè)沒有及時披露信息、披露的信息存在虛假陳述、隱藏企業(yè)的內(nèi)幕交易等等。這些問題的存在會對社會廣大投資者的利益造成嚴重的侵害,并且阻礙我國證券市場的良好發(fā)展。企業(yè)一旦發(fā)生上述信息披露違規(guī)的行為,就會使廣大投資者對該公司原有的信心造成嚴重的打擊,往往因此導致企業(yè)出現(xiàn)了誠信危機。在這樣的背景下,本文選取了具有典型性的上市公司紫鑫藥業(yè)作為研究目標,全文框架如下:第一部分是緒論,主要闡述了文章的選題背景及研究目的和意義、研究的內(nèi)容和方法。第二部分為案例描述,首先對文章中所選取的案例公司做出簡要的介紹,以及其會計信息披露現(xiàn)狀,然后介紹紫鑫藥業(yè)財務造假案件的始末。第三部分為案例分析,首先介紹信息披露的相關理論,再詳細分析紫鑫藥業(yè)在信息披露中存在的問題,并對紫鑫藥業(yè)信息披露違規(guī)的原因進行詳細的分析。第四部分為對策與建議。針對紫鑫藥業(yè)會計信息披露違規(guī)問題,提出相應的改進措施和對策建議。第五部分是結束語。本文從近年來發(fā)生的紫鑫藥業(yè)違規(guī)披露會計信息這一事件出發(fā),較為深入的研究了該公司信息披露違規(guī)背后的原因,并找到該公司存在的缺陷。從而反映出該公司在信息披露上存在的問題。通過結合這些問題,對提高該公司信息披露的質(zhì)量給予了針對性的意見和建議,以期給其他公司一些參考借鑒。
[Abstract]:Information users understand the company's business results, financial situation and other information through accounting information disclosed by enterprises, so as to make correct and reasonable economic decisions. The quality of accounting information disclosure is good or bad. It has a great impact on corporate governance, because it can reflect the governance of the middle and senior management of the enterprise. At the same time, it plays a protective role for the small and medium-sized shareholders of the enterprise. It can also better promote the healthy and orderly development of our securities market. In recent years, most listed companies in China have made a lot of improvements in terms of information disclosure. However, there are still many problems that can not be ignored. More and more reports have been made on the irregularities in information disclosure of listed companies in China, and even many companies have been ordered and punished by the relevant regulatory authorities. At present, There are still many problems in information disclosure of listed companies in our country. For example, enterprises have not disclosed information in a timely manner, and the information disclosed has been misrepresented. Hidden insider trading of enterprises and so on. The existence of these problems will cause serious damage to the interests of the broad masses of investors in society, and hinder the good development of the securities market in our country. This will cause the majority of investors to deal a serious blow to the original confidence of the company, which often leads to a credit crisis in the enterprise. Under such a background, this paper selects Zixin Pharmaceutical, a typical listed company, as the research goal. The first part is the introduction, which mainly describes the background, purpose and significance of the research, the content and method of the research. The second part is the case description, first of all, a brief introduction to the selected case companies in the article. And its current situation of accounting information disclosure, then introduces the beginning and end of the financial fraud cases of Zixin Pharmaceutical Industry. The third part is the case study. First, it introduces the relevant theory of information disclosure, and then analyzes in detail the problems existing in the information disclosure of Zixin Pharmaceutical Co., Ltd. And the reasons for the violation of information disclosure in Zixin Pharmaceutical Industry are analyzed in detail. Part 4th is the countermeasure and suggestion, aiming at the problem of accounting information disclosure violation in Zixin Pharmaceutical Industry. Put forward the corresponding improvement measures and countermeasures and suggestions. 5th part is the conclusion. This article proceeds from the recent events of the Zixin pharmaceutical industry to disclose accounting information illegally, and deeply studies the reasons behind the violation of the information disclosure in this company. And find out the defects of the company. This reflects the problems in the information disclosure of the company. By combining these problems, it gives specific opinions and suggestions to improve the quality of the information disclosure of the company. In order to give other companies some reference.
【學位授予單位】:遼寧大學
【學位級別】:碩士
【學位授予年份】:2016
【分類號】:F406.7;F426.72
【參考文獻】
相關期刊論文 前10條
1 黃軼飛;劉玉峰;;上市公司會計信息披露法律責任的弱化治理[J];會計之友;2014年29期
2 田巧娣;解恒慧;;公司治理對會計信息披露質(zhì)量影響的實證分析[J];財會通訊;2013年30期
3 譚相興;田海霞;;上市公司會計信息披露質(zhì)量問題及成因分析[J];現(xiàn)代商業(yè);2013年06期
4 張淑霞;;基于公司公告的會計信息披露研究[J];財會通訊;2012年30期
5 陳繼初;;信息披露質(zhì)量對會計信息價值相關性的影響[J];財會月刊;2012年30期
6 朱繼祥;;論上市公司會計信息披露的時效性和有效性[J];現(xiàn)代商業(yè);2011年35期
7 曹皖青;韓煦;;董事會特征對會計信息披露質(zhì)量的影響[J];山西財經(jīng)大學學報;2011年S3期
8 齊萱;何賢茂;;上市公司自愿性會計信息披露現(xiàn)狀及改進措施[J];會計之友;2011年28期
9 韓道琴;;公司治理與會計信息披露質(zhì)量關系研究[J];經(jīng)濟縱橫;2011年09期
10 譚軼;;從信息需求者論會計信息可靠性與相關性[J];會計之友;2011年16期
相關碩士學位論文 前6條
1 李艷;董事會特征對我國上市公司會計信息披露質(zhì)量的影響研究[D];西南大學;2014年
2 包楠;上市公司會計信息披露質(zhì)量問題研究[D];首都經(jīng)濟貿(mào)易大學;2014年
3 彭睿;基于公司治理的國有控股公司會計信息披露的博弈分析[D];山東財經(jīng)大學;2013年
4 李春梅;我國上市公司會計信息披露有效性研究[D];山東財經(jīng)大學;2013年
5 唐文麗;董事會特征對上市公司會計信息披露質(zhì)量的影響研究[D];東華大學;2013年
6 樸琳華;我國上市公司會計信息披露有效性研究[D];東北師范大學;2010年
,本文編號:1532460
本文鏈接:http://sikaile.net/guanlilunwen/caiwuguanlilunwen/1532460.html